|
HS Code |
921374 |
As an accredited 2-Iodo-3-Bromofluorobenzene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Iodo-3-Bromofluorobenzene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
There’s nothing particularly flashy about the clear, slightly yellowish liquid known as 2-Iodo-3-Bromofluorobenzene, but seasoned chemists know to treat every halogenated aromatic compound with a close eye. With a molecular formula of C6H3BrF I and a relatively hefty molar mass, this compound stands out in any storeroom simply because it combines iodine, bromine, and fluorine in one tightly packed benzene ring. Each of these atoms brings its own flavor to the table—fluorine’s immovable electronegativity, bromine’s useful reactivity, and iodine’s sheer bulk and ability to undergo transformations that smaller halides can’t handle. Holding a bottle of this compound inspires a sense of possibility, knowing it opens pathways in both academic research and industrial labs.
Many organic chemists still remember the rush of analyzing halogenated arenes by NMR, the spectrum cluing you in on where each substituent sits. With 2-Iodo-3-Bromofluorobenzene, the unique orientation of the halogens on the benzene ring creates just enough difference in reactivity to matter for reactions like Suzuki couplings, metal-halogen exchange, or direct aromatic substitution. The fluorine atom’s presence generally protects the ring from unwanted nucleophilic attack, while the iodine practically begs for palladium catalysis to snap it off in favor of another usefully functional group. This blend gives researchers an edge when developing new pharmaceuticals, agrochemicals, or even advanced materials.
I’ve seen plenty of variations on aromatic halides, and most serve very particular purposes. Monohalogenated benzenes give a decent entry point for modification, but the world rarely stops at “decent.” Swap a single halogen for two, especially in positions that encourage both selectivity and reactivity, and suddenly you get a compound like 2-Iodo-3-Bromofluorobenzene. It’s deliberately designed for chemoselective transformations. The iodine often acts as the starting gate for a quick coupling, while the bromine sits in reserve, ready for a second transformation once the chemist proves the initial route works. Unlike symmetrical dihalides, which can leave you fighting messy isomer mixtures, the 2- and 3- positions arranged around the fluorine give a reliable launching pad for sequential reactions.
Fluorinated benzene derivatives have a reputation for adding stability and unique biological profiles to final products. The trifecta of halogens here means synthetic strategies branch off in many directions. Medicinal chemists especially appreciate the almost modular way this intermediate can be incorporated into new lead molecules. By having three handle points, each ready for different reaction conditions, research doesn’t stall at trial-and-error. Instead, project timelines speed up, absorbing hiccups without major reroutes. That efficiency translates into cost savings and less chemical waste.
Line up 2-Iodo-3-Bromofluorobenzene with more standard halides like bromofluorobenzenes or iodofluorobenzenes, and the distinctions quickly become clear. Monosubstituted rings don’t offer nearly the same synthetic control. Trying to achieve selective cross-coupling on 1,2-dibromobenzene, for example, risks accidental bis-coupling unless you carefully fine-tune your conditions, and even then, partial conversion plagues scalability. Add an ortho-iodo substituent ortho- to a bromine, and that iodo group serves almost like a chemical “easy button,” letting you run a milder, more predictable reaction.
Fluorinated arenes also tend to have higher metabolic stability, which helps create drugs that survive the acidic stew of the stomach and liver longer—translating to better bioactivity. By using 2-Iodo-3-Bromofluorobenzene as a starting point, both pharmaceutical and agricultural researchers streamline their routes to complex final products. In my experience, labs focused on new crop protectants or next-gen pharmaceuticals choose this intermediate to build in those favorable halogen effects from the very beginning. The alternative, adding a fluorine late in the process, gets clunky—imperfect selectivity, lower yields, frustration all around.
I’ve worked on projects where the difference between a week of trial reactions and an afternoon of success came down to careful substrate selection. 2-Iodo-3-Bromofluorobenzene’s main draw lies in its positional substitution pattern. The iodine at position 2 isn’t just a random addition; it’s a deliberate choice for workhorse cross-couplings. With good quality starting material, a researcher can run a straightforward Suzuki or Sonogashira reaction right off the bat, using tried-and-true catalysts with minimal tweaking. Once the desired group takes iodine’s place, the remaining bromine can handle a separate coupling under slightly more vigorous conditions. You can see a logic here that prioritizes workflow, saving time, reagents, and headaches.
Fluorinated aromatics have a long legacy as key parts of molecules that need to combine rigidity, lipophilicity, and resistance to metabolism. In some medicinal chemistry roles, adding a fluorine boosts potency or blocks unwanted breakdown, so having a precursor with all three halogens tightens up the synthesis route. Multiple halogens also open up regioselective functionalization—allowing the chemist to push selectivity without overly complex protecting group strategies. Such design thinking shows up in both academic papers and commercial-synthesis routes across global labs.
Labs aren’t buying 2-Iodo-3-Bromofluorobenzene just to store it on the shelves. This compound anchors itself in freelance research teams, contract manufacturing outfits, and Fortune 500 pharma companies alike. In the pharmaceuticals world, the molecule often serves as a scaffold for drugs that need specific halogen placement for activity, solubility, or resistance to metabolic breakdown. Many custom synthesis shops know the value of a reliable multi-halogenated intermediate—they can offer clients a shorter route to a custom target by suggesting this as a building block.
In my broader research circles, crop science is another area where such intermediates shine. Herbicides and fungicides benefit from fluorinated aromatics that last just long enough in the field to take effect, without lingering unnecessarily in the food chain. 2-Iodo-3-Bromofluorobenzene lays the groundwork for those structures, opening up modifications that can tailor a product’s breakdown profile or receptor selectivity.
Material science teams, though smaller in number, sometimes rely on these multi-halogenated benzenes to serve as monomers or crosslinking agents for specialty polymers. The unique combination of halogens lowers the polymerization temperature or affects post-polymer-modification paths, giving performance advantages that would be complicated or expensive to achieve another way. Every time a new OLED or display material debuts in the tech sector, it’s safe to assume a few such intermediates played quiet roles along the way.
Most trained chemists have a mental Rolodex of safety rules once they’re dealing with halogenated aromatics, and 2-Iodo-3-Bromofluorobenzene is no exception. I’ve watched new grads walk through their first day handling it—double gloves, working under a vent hood, careful pipetting. Iodine compounds can stain skin or pose a vapor risk; bromides can irritate. Storage in airtight amber bottles, away from strong acids and bases, keeps the product stable and contamination-free.
Facility managers invest in good ventilation and emergency eyewash stations. Waste management companies know halogenated waste needs careful containment and incineration. Over my years in the lab, seeing these protocols followed shows a commitment not just to regulatory compliance but to protecting health and scientific progress. Risk can’t be erased, but care and training make all the difference.
Like most specialty chemicals, 2-Iodo-3-Bromofluorobenzene doesn’t always appear in distributor catalogs, but global demand has shaped a fairly steady supply within research regions. The compound owes much of its cost and availability to fluctuations in halogen source pricing and regulatory controls. A disruption in raw iodine feeds or bromine refinement can send shockwaves up the value chain, leading to sudden price hikes or slow shipping. As an industry observer, I’ve seen certain years where this intermediate went from easy-access commodity to hard-to-get hot item.
Labs that plan ahead place blanket orders and keep tight tabs on both purity and lead times. Intellectual property and material traceability factor into these decisions. A reliable batch from a trusted vendor often carries a premium, but no one wants to risk contamination or inconsistent reaction outcomes due to a bad lot. Here’s where quality control labs and supply managers earn their keep—catching purity drops or lot-to-lot drift long before it torpedoes a major project. In a world where a week’s delay can cost thousands, supply chain resilience becomes a prized trait.
Anyone working closely with multi-halogenated aromatics grapples with their environmental impact. Halogenated waste can be persistent, and improper disposal risks long-term soil and water problems. In recent years, the chemical industry has started to tackle greener synthesis methods. Flow chemistry and alternative reaction solvents get a serious look—not just to cut costs, but to limit hazardous byproducts.
Many academic groups, catalyzed by environmental regulations and growing public concern, have launched research aimed at reducing the halogen burden or designing intermediates that degrade cleanly post-use. There’s a push towards catalytic couplings that minimize metal use and solvent volumes. The very structure that makes 2-Iodo-3-Bromofluorobenzene so powerful for synthesis—a densely packed, substitution-ready ring—also presents hurdles to complete biodegradation. Balancing these strengths against stewardship responsibilities is a conversation happening at every level of research and manufacturing.
Industry-wide, programs that encourage take-back and proper destruction of residual stock have grown in popularity. Labs like the one I trained in began sharing best practices—tracking quantities, labeling meticulously, and using stabilizing packaging—to prevent both short-term risks and long-term cleanup headaches. The chemical industry’s conservative approach to innovation sometimes makes real progress feel slow, but the trend is clear: no one can afford to treat persistent waste as someone else’s problem.
Chemists working at the bench rarely face textbook conditions. At scale, things get messy: reaction yields drop, solvents misbehave, and unexpected side products crop up. One advantage I noticed with 2-Iodo-3-Bromofluorobenzene over other halobenzenes is how it seems to “play nicely” during scale-up. Its defined reactivity often helps avoid over-reaction or excessive byproduct formation. Labs looking to get more than a few grams at a time find that key intermediates like this tend to maintain their clean reaction profiles across larger runs.
Still, issues can crop up. I remember troubleshooting a failing cross-coupling that looked flawless on a small scale, only to discover that trace contaminants in the halide source wrecked yields in larger batches. The lesson? Not all sources of 2-Iodo-3-Bromofluorobenzene are created equal. A small impurity can have outsized effects on precious-catalyst reactions. In academic settings, this can mean weeks of delays re-purifying batches, while in industry, unexpected reprocessing eats into profit and threatens delivery dates on multi-million-dollar contracts.
Some resourceful teams switch suppliers or institute extra quality checks for every new delivery. They test each lot with a small-scale “dummy” reaction before committing to a production run. These practical safeguards come from hard-earned experience and highlight how one misstep in sourcing leads to broader project risks.
With all its strengths, 2-Iodo-3-Bromofluorobenzene isn’t a panacea. Chemists still search for more cost-effective, environmentally gentle alternatives. The recent explosion of interest in direct C–H activation has nudged some teams toward bypassing heavy halogen intermediates altogether. Yet, the precision and reliability of sequential aromatic halide manipulations keep this compound in the limelight.
The future likely holds a blend of strategies: keeping classics like 2-Iodo-3-Bromofluorobenzene for challenging cases, while adopting greener, more atom-efficient routes where possible. Smart process engineers adapt existing reactions—rewiring older protocols to use water, greener solvents, or alternative bases—extending the working life of this intermediate in a world slowly prioritizing both sustainability and innovation.
I’ve noticed that start-ups looking to commercialize novel therapeutics or new agricultural agents still reach for time-tested, reliable intermediates. They’re willing to absorb higher up-front costs if it means fewer synthetic unknowns on the way to clinical or regulatory testing. Fortunately, better analytics—high-res mass spec, automated chromatography, and machine learning predictions—make it possible to predict, minimize, and fix process hiccups before they turn into disasters. It gives 2-Iodo-3-Bromofluorobenzene and compounds like it a continued presence in the most advanced labs.
Solving the persistent issues tied to multi-halogenated aromatics means tackling both human and technical factors. Open communication between synthetic chemists, suppliers, safety officers, and environmental consultants keeps projects running smoothly. Labs do well to standardize handling procedures and share troubleshooting tips for reaction oddities, contamination, and byproduct control.
Collaboration with upstream suppliers can offer benefits, from securing high-purity stock to early notification of supply hiccups. I’ve seen fruitful partnerships arise when researchers give real feedback to chemical vendors—sharing yield data, highlighting side-product trends, or flagging impurities that slip past vendor testing. Such data help suppliers tighten quality specs and ultimately improve everyone’s results.
Research teams dedicated to green chemistry have a unique chance to develop new catalytic systems or engineer microbes capable of processing persistent halogenated waste. Already, industry is seeing biodegradable packaging and advanced chemical recycling make inroads into sectors once considered untouchable. Pushing for innovations that let chemists cleanly dehalogenate intermediates after use could transform environmental management in the coming decade.
Bringing 2-Iodo-3-Bromofluorobenzene into the lab isn’t just about crossing another compound off the inventory list; it’s about opening new possibilities in synthetic design. Its structure elegantly showcases the benefits of calculated risk-taking in chemical innovation—balancing reactivity, selectivity, cost, and downstream impact. Personal experience and conversations with others in the field have reinforced the message that progress in chemistry relies as much on the clever use of what’s available as it does on dreaming up new molecules altogether.
As regulatory structures shift, environmental anxieties increase, and competition sharpens, the products with a proven track record—like this one—maintain their role as tools for both discovery and industrial success. Users who approach these compounds with purpose, skill, and responsibility will keep finding them at the center of tomorrow’s research breakthroughs.